KathleenWyneMDPhD

PubMed

• Comparative Effectiveness of Hybrid Closed-Loop Automated Insulin Delivery Systems Among Patients with Type 1 Diabetes.
  Sara Folk, Janet Zappe, Kathleen Wyne, Kathleen M Dungan> ;Journal of Diabetes Science and Technology. 2024 Apr 1
• Effect of Lower Extremity Nerve Decompression in Patients with Painful Diabetic Peripheral Neuropathy: The DNND Randomized, Observation Group- and Placebo Surgery-cont...
  Wolfe, G., Hynan, L., Fulmer, R., Sanchez, C., Gorman, A., Rozen, S., Vernino, S., Raskin, P., Wyne, K., Pandian, G., Sharma, S., Mohanty, A., Hembd, A.> ;Annals of Surgery. 2024 Feb 8
• Applying National Diabetic Care Standards for the Management of a Hispanic Population Attending a Free Clinic.
  Emily Lawson, Vamsee Vemulapalli, Anthony Barnes, Sara Scott, Kathleen Wyne, Summit Shah> ;Journal of Community Health. 2023 Aug 1
• 11 citations
  Hypothyroidism Prevalence in the United States: A Retrospective Study Combining National Health and Nutrition Examination Survey and Claims Data, 2009-2019.
  Kathleen L Wyne, Lekshmi Nair, Chris P Schneiderman, Brett Pinsky, Oscar Antunez Flores, Dianlin Guo, Bruce Barger, Alexander H Tessnow> ;Journal of the Endocrine Society. 2022 Nov 17
• 3 citations
  COVID-19 Vaccination Rates and Vaccine Hesitancy Among Spanish-Speaking Free Clinic Patients.
  Alexandra Scheiber, Teresa B Prinster, Hunter Stecko, Tina Wang, Sara Scott, Summit H Shah, Kathleen Wyne> ;Journal of Community Health. 2023 Feb 1
• Predictors of change in hypoglycemia unawareness among patients with type 1 diabetes.
  Kathleen Wyne, Kathleen Dungan, Melnychuk, J.> ;Diabetes/metabolism Research and Reviews. 2022 Nov 1
• 15 citations
  Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity.
  David Bradley, Alan J Smith, Alecia Blaszczak, Dharti Shantaram, Stephen M Bergin, Anahita Jalilvand, Valerie Wright, Kathleen L Wyne, Revati S Dewal, Lisa A Baer, Kat...> ;Nature Communications. 2022 Sep 24
• 2 citations
  Effectiveness of a Diabetes-Focused Electronic Discharge Order Set and Postdischarge Nursing Support Among Poorly Controlled Hospitalized Patients: Randomized Controll...
  Audrey White, David Bradley, Elizabeth Buschur, Cara Harris, Jacob LaFleur, Michael Pennell, Adam Soliman, Kathleen Wyne, Kathleen Dungan> ;JMIR Diabetes. 2022 Jul 26
• 3 citations
  The Impact of a Diabetes Transitions of Care Clinic on Hospital Utilization and Patient Care.
  Alyssa Rinaldi, Melissa Snider, Amy James, Cara Harris, Kelly Cephas Hill, Junan Li, Kathleen Wyne> ;The Annals of Pharmacotherapy. 2023 Feb 1
• JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk.
  Kathleen L Wyne, Sheldon E Litwin, Kenneth Cusi, John R Guyton> ;Journal of Clinical Lipidology. 2022 Apr 17
• 1 citations
  Influence of Literacy, Self-Efficacy, and Social Support on Diabetes-Related Outcomes Following Hospital Discharge.
  Audrey White, Elizabeth Buschur, Cara Harris, Michael L Pennell, Adam Soliman, Kathleen Wyne, Kathleen M Dungan> ;Diabetes, Metabolic Syndrome and Obesity. 2022 Jan 1
• 20 citations
  Diabetes following acute pancreatitis
  Phil A. Hart, David Bradley, Darwin L. Conwell, Kathleen Dungan, Somashekar G. Krishna, Kathleen Wyne, Melena D. Bellin, Dhiraj Yadav, Dana K. Andersen, Jose Serrano, ...> ;The Lancet. Gastroenterology & Hepatology. 2021 Aug 1
• 93 citations
  Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of ...
  Yehuda Handelsman, Paul S. Jellinger, Chris K. Guerin, Zachary T. Bloomgarden, Eliot A. Brinton, Matthew J. Budoff, Michael H. Davidson, Daniel Einhorn, Sergio Fazio, ...> ;Endocrine Practice. 2020 Oct 1
• 28 citations
  Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different
  Alice Y. Y. Cheng, Dhiren Patel, Timothy S. Reid, Kathleen Wyne> ;Advances in Therapy. 2019 Mar 30
• Corrections.
  Handelsman, Y.,Wyne, K.,Cannon, A.,Shannon, M.,Schneider, D.> ;J Manag Care Spec Pharm. 2019 Feb 27
• 6 citations
  Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists.
  Yehuda Handelsman, Kathleen Wyne, Anthony Cannon, Michael H. Shannon, Doron Schneider> ;Journal of Managed Care & Specialty Pharmacy. 2018 Aug 29
• 11 citations
  Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus.
  Liana K. Billings, Yehuda Handelsman, Michael Heile, Doron Schneider, Kathleen Wyne> ;Journal of Managed Care & Specialty Pharmacy. 2018 Aug 29
• 6 citations
  Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications.
  Michael Heile, Kathleen Wyne, Liana K. Billings, Anthony Cannon, Yehuda Handelsman, Michael H. Shannon> ;Journal of Managed Care & Specialty Pharmacy. 2018 Aug 29
• 2 citations
  GONADOPENIA AND AGING IN MEN
  Sandeep Dhindsa, Michael S. Irwig, Kathleen Wyne> ;Endocrine Practice. 2018 Apr 16
• 7 citations
  A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
  Riccardo Candido, Kathleen Wyne, Ester Romoli> ;Diabetes Therapy. 2018 Apr 13
• 24 citations
  Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysis.
  Zsolt Hepp, Kathleen Wyne, Shivaji Manthena, Siting Wang, Ved V. Gossain> ;Current Medical Research and Opinion. 2018 Jun 25
• The Yin and Yang Between Plasma Glucose Levels and Cortisol Replacement Therapy in Schmidt's Syndrome.
  Christopher A Newton, Eleni Sheehan, Kathleen Wyne, Kenneth Cusi, Julio A. Leey, Hans K. Ghayee> ;Journal of Investigative Medicine High Impact Case Reports. 2017 Jul 6
• 646 citations
  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE
  Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit, Zachary T. Bloomgarden, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris K. Guerin, David S.H. Bell, J...> ;Endocrine Practice. 2017 Apr 24
• 6 citations
  Insulin Pump Malfunction During Hospitalization: Two Case Reports
  Eileen R Faulds, Kathleen Wyne, Elizabeth O. Buschur, Jodi C. McDaniel, Kathleen Dungan> ;Diabetes Technology & Therapeutics. 2016 Jun 3
• The World and Lipidology as It Relates to Cardiology
  Edward A. Gill, Kathleen Wyne, Christie M. Ballantyne> ;Cardiology Clinics. 2015 May 1
• Join now to see all

Journal Articles

• A novel mechanism of inherited TBG deficiency: mutation in a liver specific enhancer  
  Ferrara AM, Pappa T, Fu J, Brown CD, Peterson A, Moeller LC, Wyne K, White KP, Pluzhnikov A, Trubetskoy V, Nobrega M, Weiss RE, Dumitrescu AM, Refetoff S, J Clin Endocrinol Metab, 1/1/2015
• American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive...  
  Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP,Garber A..., Endocr Pract, 1/1/2015
• Lifestyle treatment of prediabetes  
  McLellan KCP, Wyne KL, Villagomez ET, Hsueh WA, Practical Diabetology, 1/1/2015
• Driving with diabetes  
  Wyne KL, Practical Diabetology, 1/1/2015
• The world and lipidology as it relates to ca  
  Gill EA, Wyne KL, Ballantyne CM, Cardiol Clin, 1/1/2015
• What is the role of glucose control in the prevention of cardiovascular disease in type 2 diabetes?  
  Wyne KL, Practical Diabetology, 1/1/2015
• American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of Testosterone and Cardiovascular Risk  
  Goodman N, Guay A, Dandona P, Dhindsa S, Faiman C, Cunningham GR; AACE Reproductive Endocrinology Scientific Committee, Endocr Pract, 1/1/2015
• Start by Listening to the Patient  
  Wyne KL, Practical Diabetology, 1/1/2014
• Weight Management and Diabetes  
  Wyne KL, Practical Diabetology, 1/1/2014
• Screening for Type 1 Diabetes  
  Wyne KL, Practical Diabetology, 1/1/2014
• A controlled trial of renal denervation for resistant hypertension  
  Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; S..., N Engl J Med, 1/1/2014
• Fatty liver disease as a cardiovascular disease risk equivalent  
  Mohameed AT, Monsour HP Jr, Wyne KL, Practical Diabetology, 1/1/2014
• Pharmacologic treatment of prediabetes  
  McLellan KCP, Wyne KL, Villagomez ET, Hsueh WA, Practical Diabetology, 1/1/2014
• Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus  
  Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire..., N Engl J Med, 1/3/2013
• Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial  
  Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield J, Ramachandran A, Riddle M, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein H; TIDE Trial Investigators, Diabetologia, 1/1/2012
• Fatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment  
  Monsour HP Jr, Frenette CT, Wyne K, Methodist Debakey Cardiovasc J, 1/1/2012
• Renin-Angiotensin-Aldosterone system in diabetes and hypertension  
  Hsueh WA, Wyne K, J Clin Hypertens, 1/1/2011
• TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team The effects of salsalate on glycemic control in patients with type 2 diabetes: a rand...  
  Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE, Ann Intern Med, 1/1/2010
• Prediabetes: the importance of early identification and intervention  
  Hsueh WA, Orloski L, Wyne K, Postgraduate Medicine, 1/1/2010
• Insulin Therapy in Type 2 Diabetes  
  Wyne KL, Mora PF, Endocrine Research, 1/1/2007
• The effect of hyperglycemia and its therapies on the heart  
  Wyne KL, Heart Failure Clinics of North America, 1/1/2006
• How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?  
  Wyne KL, Fishbane S, Block GA, Warburton K, Berns JS, Neu AM, Warady BA, Seminars in Dialysis, 1/1/2006
• A Cognitive/Behavioral group intervention for weight loss in patients treated with atypical antipsychotics  
  Weber MT and Wyne KL, Schizophrenia Research, 1/1/2006
• The Metabolic Syndrome: Evolving evidence that thiazolidinediones provide rational therapy  
  Wyne KL, Diabetes, Obesity and Metabolism, 1/1/2006
• Treatment of type 2 diabetes Use of fixed-dose oral combinations  
  Bell DSH and Wyne KL, Postgraduate Medicine, 1/1/2006
• Join now to see all

Books/Book Chapters

• Clinical Challenges in Dyslipidemia Management 
  Chapter: What is the Metabolic Syndrome, How do I Treat it, and Is it a High Risk Condition? 
  Wyne KLEditors: Peter Toth and Domenic Sica.2008
• Diabetes Essentials 
  O’Keefe JH Jr, Bell DSH, Wyne KL and Haffner SMPhysicians’ Press, Royal Oak, MIEdition 3rd,2007
• Clinical Diabetes: Translating Research into Practice 
  Chapter: Managing Cardiovascular Disease and Events in The Patient with Diabetes 
  Wyne KLEditors: Vivian Fonseca.Elsevier Press2006
• Diabetes Essentials 
  O’Keefe JH Jr, Bell DSH, Wyne KL and Haffner SMPhysicians’ Press, Royal Oak, MIEdition 1st,2004
• Textbook of Type 2 Diabetes 
  Chapter: Insulin Therapy in Type 2 Diabetes 
  Rosenstock J and Wyne KLEditors: Barry Goldstein and Dirk Mueller.WielandEdition 1st,2003
• 7th International Symposium on Atherosclerosis Melbourne, Australia 
  Chapter: Dietary and hormonal regulation of apo E synthesis and secretion 
  Getz G, Driscoll D, Blix P, Diller P, Fox JC, Schreiber JR and Wyne KLEditors: NH Fidge and PJ Nestel.Exerpta Medica, Amsterdam1986
• Diabetes Essentials 
  O’Keefe JH Jr, Bell DSH, Wyne KL and Haffner SMPhysicians’ Press, Royal Oak, MIEdition 2nd,
• Join now to see all

Abstracts/Posters

• Effect of Canagliflozin on Triglyceride/High-Density Lipoprotein-C: A Marker of Insulin Resistance in Patients With Type 2 Diabetes Mellitus
  Wyne KL, Ziboh A, Vijapurkar U, Davies M, Meininger G, American College of Cardiology 64th Annual Scientific Session and Expo, San Diego, CA, 1/1/2015
• Is 0.5 the Optimal Waist-to-Height Ratio for Predicting Cardio-Metabolic Risk in Children?
  Shan DK, Guerra R, Wyne KL, National Lipid Association Annual Scientific Sessions, Chicago, IL, 1/1/2015
• What is the Optimal Waist-to-Height Ratio for Predicting CardioMetabolic Risk in Children?
  Shan DK, Guerra R, Wyne KL, American Society for Preventive Cardiology, 4th Annual Cardiovascular Disease Prevention Conference, Boca Raton, FL, 1/1/2015
• Dyslipidemia and Insulin Resistance in Nondiabetic Subjects with Fatty Liver Disease
  Wyne KL, Shen Y-TS, Folb LC, Monsour HP, National Lipid Association Annual Scientific Sessions, Orlando, FL, 1/1/2014
• Physician Awareness of the Guidelines on Diagnosis of Metabolic Syndrome
  Shan T, Wyne KL, Desai S, Wollner M, National Lipid Association Annual Scientific Sessions, Orlando, FL, 1/1/2014
• Hyperinsulinemia and Insulin Resistance in NAFLD Patients without Diabetes
  Folb LC, Shen Y-TS, Monsour HP, Hsueh WA, Wyne KL, American Association of Clinical Endocrinology 23rd Annual Scientific & Clinical Congress, Las Vegas, NV, 1/1/2014
• Implementation of a Hospital Policy Requiring Diabetes Team Evaluation for Insulin Pump Use as an Inpatient
  Wyne KL, Schwartz TE, Sadhu A, Hsueh WA, American Association of Clinical Endocrinology 23rd Annual Scientific & Clinical Congress, Las Vegas, NV, 1/1/2014
• Insulin Resistance and Beta-Cell Function in Nonalcoholic Fatty Liver Disease
  Wyne KL, Shen Y-TS, Folb LC, Monsour HP, 50th Annual Meeting of the European Association for the Study of Diabetes, Vienna, Austria, 1/1/2014
• Ethnic Differences in Brown Fat
  Hsueh WA, Wyne, KL, Zhu Y, Villagomez E, Peterson L, 72th Scientific Sessions, American Diabetes Association, Philadelphia, PA, 1/1/2012
• Patient Specific T2 Correction in Hepatic Fat Content Measurement
  Tang AM, Wong KK, Wyne KL, Shungu DC, Hsueh WA, Wong ST, ISMRM-ESMRMB Joint Annual Meeting, Stockholm, Sweden, 1/1/2010
• A Social Cohesion Model for Successful Weight Management in Young Women
  Villagomez ET, Wyne KL, Hsueh WA, 82nd Annual Meeting, Endocrine Society, San Diego, CA, 1/1/2010
• Prevalence of Brown Fat at The Methodist Hospital in Houston, Texas
  Wyne, KL, Zhu Y, Villagomez E, Peterson L and Hsueh WA, 70th Scientific Sessions, American Diabetes Association, Orlando, FL, 1/1/2010
• The Prevalence of Brown Fat at The Methodist Hospital in Houston, Texas is not Affected by the Season
  Wyne, KL, Zhu Y, Villagomez E, Peterson L and Hsueh WA, 8th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease, Los Angeles, CA, 1/1/2010
• The Use of Labetalol in the Setting of Thyrotoxicosis and Cocaine-Induced Myocardial Infarction
  Sukumar S, Chang AY, Welch BJ, Kovacs W, Wyne K, 88th Annual Meeting, Endocrine Society, Boston, MA, 1/1/2006
• The Effects of Rosiglitazone in Poorlycontrolled, Drug-naive Patients with Type 2 Diabetes Mellitus
  Wyne KL, Cobitz A, Waterhouse B, and Strow L, 64th Annual Scientific Meetings and Sessions, American Diabetes Association; 40th Annual Meeting, European Association for the Study of Diabetes, Orlando, FL, 2004; Munich, Germany, 2004, 1/1/2004
• Alteration in the tissue and signal transduction characteristics of the bladder may be responsible for its susceptibility to recurrent infections in diabetes
  Handel L, Ferucci P, Lowe JB, Banerjee A, Daneshgari F, Wyne KL, 26th Congress of the Societe Internationale d’Urologie, Stockholm, Sweden, 1/1/2002
• A new genetic rat model of insulin-dependent diabetes without insulitis
  Wyne KL, Esser V, Comerford SA, Hammer RE and McGarry JD, 58th Annual Scientific Meetings and Sessions, American Diabetes Association, Chicago, IL, 1/1/1998
• A new genetic rat model of severe insulin deficiency without insulitis
  Esser V, Wyne KL, Comerford SA, Hammer RE and McGarry JD, 34th Annual Meeting, European Association for the Study of Diabetes, Barcelona, Spain, 1/1/1998
• A new genetic rat model of diabetes mellitus (dm) for studies of lower urinary tract (lut) dysfunction
  Daneshgari F, Wyne K, Lemack G, and McGarry JD, 94th Annual Meeting, American Urology Association, Dallas, TX, 1/1/1998
• Alterations in the profile and translocation of protein kinase (PKC) in normal and diabetic detrusor muscle of rat
  Banerjee A, Daneshgari F, Gamboni-Robertson F, Wyne K, Lemack G, and McGarry JD, 94th Annual Meeting, American Urology Association, Dallas, TX, 1/1/1998
• SR-Bl is an HDL receptor that mediates selective uptake of the cholesteryl esters from high density lipoprotein (HDL) and is regulated by cyclic AMP in human adrenal c...
  Wyne KL and Hobbs HH, 79th Annual Meeting, Endocrine Society, Minneapolis, MN, 1/1/1997
• The VLDL Receptor is not a primary chylomicron receptor in the mouse
  Wyne KL, Savonen R, Bengtsson-Olivecrona G, Olivecrona T, and Hobbs HH, 79th Annual Meeting, Endocrine Society, Minneapolis, MN, 1/1/1997
• Apo E synthesis by cultured human ovarian granulosa cells; regulation by hCG and cholesterol
  Schreiber JR, Wyne KL and Getz G, 71st Annual Meeting, Endocrine Society, Seattle, WA, 1/1/1989
• Regulation of apolipoprotein E synthesis in rat ovarian granulosa cells
  Schreiber JR, Wyne KL, Larsen A and Getz G, 70th Annual Meeting, Endocrine Society, New Orleans, LA, 1/1/1988
• Regulation of apolipoprotein E synthesis in an active steroidogenic cell
  Wyne KL, Getz G and Schreiber JR, 8th International Congress of Atherosclerosis, Rome, Italy, 1/1/1988
• Join now to see all

Lectures

• Application of New Lipid Guidelines to Clinical Practice: Evidence and Controversies 
  Columbus, OH - 1/20/2016
• Primary Hyperaldosteronism 
  Alexandria, Egypt - 1/12/2016
• Subclinical Cushing’s 
  Alexandria, Egypt - 1/11/2016
• Diabetes Physiology & Management 
  1/7/2016
• Cystic Fibrosis Related Diabetes (CFRD) 
  Columbus, OH, 2015, 2016 - 1/5/2016
• Fatty Liver Disease 
  Columbus, OH - 1/5/2016
• Fatty Liver: the Hidden Component of Metabolic Syndrome & "Prediabetes” 
  1/15/2015
• Real-Time CGM in Daily Practice: Patient Assessment & Interpretation 
  Nashville, TN - 1/15/2015
• Management of Adults with Type 1 Diabetes (T1D) 
  Columbus, OH - 1/13/2015
• Does Obesity = Diabetes in Women or Can a Woman be “Metabolically Healthy Obese”? 
  Findlay, OH - 1/13/2015
• Diabetes and Dyslipidemia 
  Chicago, IL - 1/13/2015
• ADA Clinical Practice Guidelines 
  Columbus, OH - 1/10/2015
• Diabetes & CVD 
  Williamsburg, VA - 1/8/2015
• Thyroid Disease: Diagnosis & Management 
  Newark, OH - 1/3/2015
• Lipids: New Guidelines and New Drugs 
  Newark, OH - 1/3/2015
• Fish Oil & Fatty Liver 
  Wailea-Makena, HI - 1/16/2014
• Comprehensive Management Strategy for Type 2 Diabetes 
  Squaw Valley, CA - 1/8/2014
• Fish Oil and Fatty Liver 
  Squaw Valley, CA - 1/8/2014
• How much accuracy is needed in the blood glucose monitors used to check finger stick glucose? A review of the recent FDA/DTS workshop 
  1/22/2013
• Challenges in weight loss and maintenance in young adult women 
  Alexandria, Egypt - 1/19/2013
• Brown Fat in Adults 
  Alexandria, Egypt - 1/17/2013
• New Options in the Medical Management of Obesity 
  Corpus Christi, TX - 1/12/2013
• Diabetes & Atherosclerosis 
  Williamsburg, VA - 1/9/2013
• NAFLD & NASH: Endocrine Considerations and Management 
  Houston, TX - 1/7/2013
• Endocrine Emergencies 
  1/12/2012
• Join now to see all

Other

• The influence of lipoproteins on synthesis of apolipoprotein E by rat ovarian granulosa cells 
  Olson L, Wyne KL, Schmit V, Gong E, Getz G and Schreiber JR, Regulatory Processes and Gene Expression in the Ovary, ed. G Gibori, Serono Symposium
  1/1/1990
• Doctoral Thesis: The Regulation of Apolipoprotein E Synthesis in Rat Ovarian Granulosa Cells 
  Wyne KL
  1/1/1988
• Master’s Paper: Characterization of the Apolipoprotein E Secretion Product from Rat Ovarian Granulosa Cells 
  Wyne KL
  1/1/1985